{
  "meta": {
    "timestamp": "2025-01-06T10:23:56.746074",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "ROCHE HLDGS AD GENUSSCHEINE NPV",
      "symbol": "RHHBY",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Pricing pressures due to high drug costs, particularly in oncology",
            "Patent expirations leading to increased competition from biosimilars",
            "Regulatory challenges across multiple regions delaying drug approvals"
          ],
          "controversies": [
            "Criticism over drug pricing strategies in emerging markets",
            "Ethical concerns regarding affordability and access to medicines"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Affordability and access to medicines, especially in low-income countries"
          ],
          "governance_issues": [
            "Navigating complex regulatory environments and potential reputational risks"
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV - TradingView",
              "snippet": "Get a brief overview of ROCHE HOLDINGS AG GENUSSCHEINE NPV financials with all the important numbers. View the latest 0QOK income statement, balance sheet, and financial ratios. ... Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.680859+00:00",
              "published_date": null,
              "source_hash": "1437ac80343db189f56b67d1994cdd87"
            },
            {
              "url": "",
              "title": "Roche Holdings AG (ROG) Shares NPV (Crest Depositary Interest)",
              "snippet": "The latest Roche Holdings AG Shares NPV (Crest Depositary Interest) share price. View recent trades and share price information for Roche Holdings AG Shares NPV (Crest Depositary Interest) We don ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681104+00:00",
              "published_date": null,
              "source_hash": "e7a4db1fb7e8583c585be5884f3cdd40"
            },
            {
              "url": "",
              "title": "Roche Holding AG Genussscheine (ROG) Stock Price & News - Google",
              "snippet": "Get the latest Roche Holding AG Genussscheine (ROG) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819084+00:00",
              "published_date": null,
              "source_hash": "a6030b975ecbc4bcbbe6696602606f19"
            },
            {
              "url": "",
              "title": "Roche Holdings Ag Genusscheine Npv",
              "snippet": "Annual report: ROCHE HOLDINGS AG GENUSSCHEINE NPV: Company Profile. Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.680990+00:00",
              "published_date": null,
              "source_hash": "ca18a05a201f718876c804087f5dae21"
            },
            {
              "url": "",
              "title": "ROCHE HOLDING AG-GENUSSCHEIN - London Stock Exchange",
              "snippet": "ROCHE HOLDING AG-GENUSSCHEIN E:ROGZ - Turquoise is the European Multilateral Trading Facility (MTF) majority owned by London Stock Exchange Group in partnership with the user community, providing members a single connection to trade securities from 19 European and emerging markets as well as US stocks, IOB Depositary Receipts, ETFs and European ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV patent litigation",
              "retrieved_at": "2025-01-06T17:23:32.710946+00:00",
              "published_date": null,
              "source_hash": "8a32831b8aaef0905d1df182a24fb464"
            },
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV - Charles Stanley Direct",
              "snippet": "ROCHE HOLDINGS AG GENUSSCHEINE NPV. Symbol: ROG. Buy 251. Sell 250.9. Price Change 3.6 (1.46%) All prices are in CHF as at 17:45 Selected data supplied by Thomson Reuters\u00a9 View Restrictions. ... Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681023+00:00",
              "published_date": null,
              "source_hash": "093333635f6f71afccec396d99c76ee0"
            },
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV Balance Sheet - TradingView",
              "snippet": "Get detailed quarterly and annual balance sheet data for ROCHE HOLDINGS AG GENUSSCHEINE NPV. View 0QOK assets, liabilities, investments, debt, and more.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681129+00:00",
              "published_date": null,
              "source_hash": "184afa6e638034cc133f13ff253b4417"
            },
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV Earnings and Revenue - TradingView",
              "snippet": "Watch ROCHE HOLDINGS AG GENUSSCHEINE NPV key financial stats \u2014 earnings and revenue. Keep track of their change over time and use estimation numbers to develop a better strategy.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681150+00:00",
              "published_date": null,
              "source_hash": "72c6ac1e9d6bc58b75b8e11f5d9b959b"
            },
            {
              "url": "",
              "title": "ROCHE GS Stock Price & Performance - ROG - SIX",
              "snippet": "ROCHE GS. Stock price and performance News; Post-Trade Forum 2024 - The Highlights . 12 Dec 2024. Show News. News; B1G Numbers November 2024: Key Figures from SIX Swiss Exchange . 02 Dec 2024. Show News. Media Releases; Robeco Becomes New ETF Issuer at SIX Swiss Exchange. 25 Nov 2024. Show News. Share on. LinkedIn; Twitter; Facebook;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV patent litigation",
              "retrieved_at": "2025-01-06T17:23:32.711004+00:00",
              "published_date": null,
              "source_hash": "ca08392e30d504b57a80d7c9ac8f85d8"
            },
            {
              "url": "",
              "title": "Company report: ROCHE HOLDINGS AG GENUSSCHEINE NPV",
              "snippet": "ROCHE HOLDINGS AG GENUSSCHEINE NPV ISIN: CH0012032048 WKN: 1203204 Asset Class: Stock Company 2024/11/26 17:31:19 Price 251.40 CHF Difference-0.83%(-2.10) Contact Details ROCHE HOLDING AG Tel: +41-61-688-11-11",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681199+00:00",
              "published_date": null,
              "source_hash": "2a1b576135afa78d7372af0b998cfc12"
            },
            {
              "url": "",
              "title": "Roche Holdings AG (ROG) Shares NPV (Crest Depositary Interest)",
              "snippet": "The latest Roche Holdings AG share price. View recent trades and share price information for Roche Holdings AG and other shares.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819009+00:00",
              "published_date": null,
              "source_hash": "1d9c4801852ed208d2ab6ce688c0ee3b"
            },
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV - TradingView",
              "snippet": "Get a brief overview of ROCHE HOLDINGS AG GENUSSCHEINE NPV financials with all the important numbers. View the latest 0QOK income statement, balance sheet, and financial ratios. ... Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. ... Pricing Social network Wall of Love ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819069+00:00",
              "published_date": null,
              "source_hash": "64465d686ab2be7d739b2d184019c240"
            },
            {
              "url": "",
              "title": "RHHVF (Roche holdings ag genusscheine npv) - TrendSpider",
              "snippet": "Free stock charts, prices, volume, market data, history, options flow, news, seasonality and more for RHHVF (Roche holdings ag genusscheine npv) on TrendSpider",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681082+00:00",
              "published_date": null,
              "source_hash": "66fdd6f25c8124809889aaf68d813f51"
            },
            {
              "url": "",
              "title": "Roche Holding AG (ROG.SW) - Yahoo Finance",
              "snippet": "Find the latest Roche Holding AG (ROG.SW) stock quote, history, news and other vital information to help you with your stock trading and investing.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819138+00:00",
              "published_date": null,
              "source_hash": "7d2f4ac076fffb609d353c2325e3df50"
            },
            {
              "url": "",
              "title": "Roche Holding AG-Genusschein - BX Swiss",
              "snippet": "Established in 1884, BX Swiss is a Swiss regulated stock exchange under the supervision of FINMA.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819147+00:00",
              "published_date": null,
              "source_hash": "75082df0774285a28f3d932a5d89166c"
            },
            {
              "url": "",
              "title": "ROCHE HOLDINGS AG GENUSSCHEINE NPV Financial Statements - TradingView",
              "snippet": "Get a brief overview of ROCHE HOLDINGS AG GENUSSCHEINE NPV financials with all the important numbers. View the latest 0QOK income statement, balance sheet, and financial ratios. ... Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. ... Pricing Social network Wall of Love ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "retrieved_at": "2025-01-06T17:23:36.819155+00:00",
              "published_date": null,
              "source_hash": "d19ef04b155ecb2d5426d2b4d538e7d3"
            },
            {
              "url": "",
              "title": "ROCHE HOLDING AG-GENUSSCHEIN - London Stock Exchange",
              "snippet": "Turquoise is the European Multilateral Trading Facility (MTF) majority owned by London Stock Exchange Group in partnership with the user community, providing members a single connection to trade securities from 19 European and emerging markets as well as US stocks, IOB Depositary Receipts, ETFs and European Rights Issues",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681057+00:00",
              "published_date": null,
              "source_hash": "fad704f1540271b2d0e625c9ddc6a2e0"
            },
            {
              "url": "",
              "title": "Roche Holding AG-Genusschein - BX Swiss",
              "snippet": "Roche Holding AG-Genusschein. Performance. 0.00% Spread. 0.07%. Bid. CHF 254.891. Vol 691. Ask. CHF 255.081. Vol 691. Last traded ... For more information on our trade definitions see the Regulatory information. BEKB I BCBE. 031 666 63 71 Credit Suisse (Schweiz) AG. 0844 800 888 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "ROCHE HLDGS AD GENUSSCHEINE NPV ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "retrieved_at": "2025-01-06T17:23:40.681177+00:00",
              "published_date": null,
              "source_hash": "3e165cc3b568b2f8e43fc883474236e5"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "ROCHE HLDGS AD GENUSSCHEINE NPV patent litigation",
              "rationale": "Investigate ongoing or past legal disputes related to patent expirations and biosimilar competition",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "ROCHE HLDGS AD GENUSSCHEINE NPV drug pricing controversies",
              "rationale": "Explore public and regulatory scrutiny over high drug prices, particularly in oncology and low-income markets",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "ROCHE HLDGS AD GENUSSCHEINE NPV regulatory delays",
              "rationale": "Assess the impact of regulatory challenges on drug approvals and market access in key regions",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T10:23:56.746081",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}